American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy

Brachytherapy

Volumn 11, Issue 1, 2012, Pages 58-67

  Small, William ^a   Beriwal, Sushil ^b   Demanes, D Jeffrey ^c   Dusenbery, Kathryn E ^d   Eifel, Patricia ^e   Erickson, Beth ^f   Jones, Ellen ^g   Rownd, Jason J ^f   De Los Santos, Jennifer F ^h   Viswanathan, Akila N ⁱ   Gaffney, David ^j  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h The University of Alabama at Birmingham   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j UNIVERSITY OF UTAH   (United States)

more..

Author keywords

Brachytherapy; Cervical neoplasm; Endometrial neoplasm; High dose rate; Low dose rate; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CLINICAL DECISION MAKING; CONSENSUS DEVELOPMENT; DOSIMETRY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE QUALITY; HUMAN; HYSTERECTOMY; MEDICAL SOCIETY; PATIENT SELECTION; PHYSICIAN; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION APPLICATOR; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING; UTERUS CANCER; VAGINA CUFF BRACHYTHERAPY;

BRACHYTHERAPY; FEMALE; HUMANS; POSTOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; UNITED STATES; VAGINAL NEOPLASMS;

EID: 84855994265     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2011.08.005     Document Type: Article

References (55)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Small W., Erickson B., Kwakwa F., et al. An American Brachytherapy Society survey regarding the practice patterns of post-operative irradiation for endometrial cancer. Int J Radiol Oncol Biol Phys 2005, 63:1502-1507.
3. Nout R.A., Smit V., Putter H., et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet 2010, 375:816-823.
4. Nag S., Orton C., Petereit D., et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000, 48:779-790.
5. Sorbe B.G., Smeds A.C. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys 1990, 18:305-314.
6. Noyes W.R., Bastin K., Edwards S.A., et al. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: A phase II clinical protocol. Int J Radiat Oncol Biol Phys 1995, 32:1439-1443.
7. Fanning J., Nanvati P.J., Hilgers R.D. Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumors. Obstet Gynecol 1996, 87:1041-1044.
8. Kloetzer K.H., Gunther R., Wendt T. The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy. Strahlenther Onkol 1997, 173:13-17. [in German].
9. Hong J.J., Yacoub S.F., Blevins J.C., et al. High dose rate vaginal brachytherapy in early stage endometrial carcinoma: Preliminary analysis. Am J Clin Oncol 1997, 20:254-258.
10. MacLeod C., Fowler A., Duval P., et al. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys 1998, 42:1033-1039.
11. Weiss E., Hirnle P., Arnold-Bofinger H., et al. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 1998, 71:72-76.
12. Petereit D.G., Tannehill S.P., Grosen E.A., et al. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer 1999, 9:456-462.
13. Chadha M., Nanavati P.J., Liu P., et al. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999, 75:103-107.
14. Eltabbakh G.H., Piver M.S., Hemping R.E., et al. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial. Int J Radiat Oncol Biol Phys 1997, 38:373-380.
15. Anderson J.M., Stea B., Hallum A.V., et al. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys 2000, 46:417-425.
16. Horowitz N.S., Peters W.A., Smith M.R., et al. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol 2002, 99:235-240.
17. Rittenberg P.V., Lotocki R.J., Heywood M.S., et al. High-risk surgical stage I endometrial cancer: Outcomes with vault brachytherapy alone. Gynecol Oncol 2003, 89:288-294.
18. Jolly S., Vargas C., Kumar T., et al. Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 2005, 97:887-892.
19. Alektiar K.M., Venkatraman E., Chi D.S., et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005, 62:111-117.
20. Solhjem M.C., Petersen I.A., Haddock M.G. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. Int J Radiat Oncol Biol Phys 2005, 62:1379-1384.
21. Cengiz M., Singh A.K., Grigsby P.W. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer. Int J Gynecol Cancer 2005, 15:926-931.
22. Atahan I.L., Ozyar E., Yildiz F., et al. Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery. Int J Gynecol Cancer 2008, 18:1294-1299.
23. Lin L.L., Mutch D.G., Rader J.S., et al. External radiotherapy versus vagina brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007, 106:215-220.
24. McCloskey S.A., Tchabo N.E., Malhotra H.K., et al. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol 2010, 116:404-407.
25. Aalders J., Abeler V., Kolstad P., et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980, 56:419-427.
26. Knocke T.H., Kucer H., Weidinger B., et al. Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: Results of 12years of experience with 280 patients. Int J Radiat Oncol Biol Phys 1997, 37:359-365.
27. Lybeert M.L.M., van Putten W.L.J., Ribot J.G., et al. Endometrial carcinoma: High dose-rate brachytherapy in combination with external irradiation; a multivariate analysis of relapses. Radiother Oncol 1989, 16:245-252.
28. Nori D., Merimsky O., Batata M., et al. Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: A long-term follow-up. Int J Radiat Oncol Biol Phys 1994, 30:831-837.
29. Algan O., Tabesh T., Hanlon A., et al. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. Int J Radiat Oncol Biol Phys 1996, 35:925-933.
30. Cannon G.M., Geye H., Terakedis B.E., et al. Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma. Gynecol Oncol 2009, 113:176-180.
31. Fayed A., Mutch D.G., Rader J.S., et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys 2007, 67:480-484.
32. NCCN practice guidelines for endometrial carcinoma. 2010. Available at Accessed January 5, 2011. http://www.nccn.org.
33. Lin L.L., Grigsby P.W., Powell M.A., et al. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer. Int J Radiat Oncol Biol Phys 2005, 63:500-504.
34. Jhingran A., Burke T.W., Eifel P.J. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003, 56:1366-1372.
35. Kim R.Y., Salter M.M., Shingleton H.M., et al. Adjuvant postoperative radiation therapy following radical hysterectomy in Stage IB cancer of the cervix: Analysis of treatment failures. Int J Radiat Oncol Biol Phys 1988, 14:445-449.
36. Houdek P.V., Schwade J.G., Abitbol A.A., et al. HDR transvaginal brachytherapy: Applicator design and dosimetry. Selectron Brachytherapy Journal 1991, (Suppl 2):28-31.
37. Maruyama Y., Ezzell G., Porter A.T., et al. Afterloading high dose rate intracavitary vaginal cylinder. Int J Radiat Oncol Biol Phys 1994, 30:473-476.
38. Demanes D.J., Rege S., Rodriquez R.R., et al. The use and advantages of a multichannel vaginal cylinder in high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1999, 44:211-219.
39. Tuncell N., Toy A., Demiral A.N., Cetingoz R., et al. Dosimetric comparison of ring and ovoid applicators. J Buon 2009, 14:451-454.
40. Sorbe B., Straumtis A., Karlsson L. Intravaginal high-dose rate brachytherapy for stage I endometrial cancer: A randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys 2005, 62:1385-1389.
41. Racine M., Viswanathan A.N. Adjuvant high-dose-rate brachtherapy alone for stage I/II endometrial adenocarcinoma using a 4-gray versus 6-gray fractionation scheme. Int J Radiat Oncol Biol Phys 2008, 72:S362. [Abstract].
42. Nag S., Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 2000, 46:507-513.
43. Choo J., Scudiere J., Bitterman P., et al. Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment. Brachytherapy 2005, 4:236-240.
44. Viswanathan A.N., Kiristis C., Erickson B.E. Gynecologic radiation therapy novel approaches to image-guidance and management 2011, Springer, New York, NY, p. 239-245.
45. Richardson S., Palaniswaamy G., Grigsby P.W., et al. Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders. Int J Radiat Oncol Biol Phys 2010, 78:276-279.
46. Miller D.A., Richardson S., Grigsby P.W. A new method of anatomically conformal vaginal Cuff HDR brachytherapy. Gynecol Oncol 2010, 116:413-418.
47. Cameron A.L., Cornes P., Al-Booz H., et al. Brachytherapy in endometrial cancer: Quantification of air gaps around a vaginal cylinder. Brachytherapy 2008, 7:355-358.
48. Holloway C.L., Macklin E.A., Cormack R.A., et al. Should the organs at risk be contoured in vaginal cuff brachytherapy. Brachytherapy 2011, 10:313-317.
49. Li Z., Liu C., Palta J.R. Optimized dose distribution of a high dose rate vaginal cylinder. Int J Radiat Oncol Biol Phys 1998, 41:239-244.
50. Samsami N., Nag S. Unintended consequences of optimized computerized treatment planning. [Abstract]. Med Phys 1999, 26:1053.
51. Gore E., Gillin M.T., Albano K., et al. Comparison of high dose-rate and low dose-rate distributions for vaginal cylinders. Int J Radiat Oncol Biol Phys 1995, 31:165-170.
52. Nath R., Anderson L.L., Meli J.A., et al. Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56. Med Phys 1997, 24:1557-1598.
53. Glasgow G.P., Bourland J.D., Grigsby P.W., et al. Remote afterloading technology: a report of AAPM Task Group No. 41 1993, American Institute of Physics, New York, NY.
54. Fraass B., Doppke M., Hunt G., et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. Med Phys 1998, 25:1773-1829.
55. Kubo H.D., Glasgow G.P., Pethel T.D., et al. High dose-rate brachytherapy treatment delivery: A report of the AAPM Radiation Therapy Committee Task Group No. 59. Med Phys 1998, 25:375-403.